To investigate if targeting USP13 to reduce Mcl-1 expression has therapeutic potential in cervical cancer, we first assessed the impact of USP13 inhibition by the small molecule inhibitor Spautin-1 [48]. This evidence concerns the gene MCL1 and cervical cancer.